Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Feb-24 1:31 PM View:  | Foose Brice 10% Owner | Invivo Therapeutics Holding... (NVIV) | 06-Feb-23 | Purchase | 164,000 | $0.46 | $75,460.00 | (100%) 164.0K to 0 | |
| 07-Feb-24 1:31 PM View: | Foose Brice 10% Owner | Invivo Therapeutics Holding... (NVIV) | 05-Feb-23 | Purchase | 166,000 | $0.29 | $47,570.00 | (50%) 330.0K to 164.0K | |
| 23-Dec-21 4:02 PM View: | Toselli Richard M. See Remarks Director | Invivo Therapeutics Holding... (NVIV) | 21-Dec-21 | Payment of Exercise | 16 | $0.54 | $8.64 | (< 1%) 6.22K to 6.2K | |
| 23-Jun-21 8:52 PM View: | Toselli Richard M. See Remarks Director | Invivo Therapeutics Holding... (NVIV) | 21-Jun-21 | Payment of Exercise | 21 | $0.74 | $15.54 | (< 1%) 6.24K to 6.22K | 3% |
| 23-Dec-20 4:14 PM View: | Toselli Richard M. See Remarks Director | Invivo Therapeutics Holding... (NVIV) | 21-Dec-20 | Payment of Exercise | 16 | $0.60 | $9.60 | (< 1%) 6.25K to 6.24K | (20%) |
| 23-Jun-20 6:35 PM View: | Toselli Richard M. See Remarks Director | Invivo Therapeutics Holding... (NVIV) | 19-Jun-20 | Payment of Exercise | 15 | $1.70 | $25.50 | (< 1%) 6.07K to 6.05K | |
| 12-Mar-20 7:01 PM View: | Christopher Richard CFO and Treasurer | Invivo Therapeutics Holding... (NVIV) | 10-Mar-20 | Purchase | 3,636 | -- | -- | 230% 1.58K to 5.22K | |
| 12-Mar-20 7:01 PM View: | Toselli Richard M. See Remarks Director | Invivo Therapeutics Holding... (NVIV) | 10-Mar-20 | Purchase | 3,636 | -- | -- | 149% 2.43K to 6.07K | |
| 12-Mar-20 7:01 PM View: | Merrifield C Ann Director | Invivo Therapeutics Holding... (NVIV) | 10-Mar-20 | Purchase | 3,636 | -- | -- | 121200% 3 to 3.64K | |
| 23-Dec-19 5:23 PM View: | Toselli Richard M. See Remarks Director | Invivo Therapeutics Holding... (NVIV) | 19-Dec-19 | Payment of Exercise | 557 | $0.16 | $89.12 | (< 1%) 79.54K to 78.99K | |
| 27-Sep-19 7:38 PM View: | Christopher Richard CFO and Treasurer | Invivo Therapeutics Holding... (NVIV) | 25-Sep-19 | Grant | 47,500 | -- | -- | 100% 0 to 47.5K | |
| 27-Sep-19 7:39 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 25-Sep-19 | Grant | 69,000 | -- | -- | 654% 10.54K to 79.54K | |
| 21-Jun-19 4:06 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 19-Jun-19 | Payment of Exercise | 72 | $0.75 | $54.00 | (< 1%) 15.84K to 15.77K | 4% |
| 27-Sep-19 7:41 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 04-Jun-19 | Market Sale | 5,229 | $0.97 | $5,072.13 | (6%) 84.77K to 79.54K | 24% |
| 22-May-19 5:55 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 20-May-19 | Payment of Exercise | 78 | $1.10 | $85.80 | (< 1%) 15.92K to 15.84K | (8%) |
| 24-Apr-19 9:43 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 22-Apr-19 | Payment of Exercise | 79 | $1.45 | $114.55 | (< 1%) 16.0K to 15.92K | (3%) |
| 20-Mar-19 6:29 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 18-Mar-19 | Payment of Exercise | 78 | $1.53 | $119.34 | (< 1%) 10.85K to 10.77K | (8%) |
| 20-Feb-19 4:10 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 18-Feb-19 | Payment of Exercise | 95 | $1.41 | $133.95 | (< 1%) 10.95K to 10.85K | < 1% |
| 22-Jan-19 8:28 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 18-Jan-19 | Payment of Exercise | 94 | $1.58 | $148.52 | (< 1%) 11.04K to 10.95K | 10% |
| 20-Dec-18 3:03 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 18-Dec-18 | Payment of Exercise | 961 | $1.69 | $1,624.09 | (8%) 12.0K to 11.04K | |
| 20-Dec-18 3:03 PM View: | Toselli Richard M. See Remarks | Invivo Therapeutics Holding... (NVIV) | 18-Dec-18 | Grant | 12,000 | -- | -- | 100% 0 to 12.0K | |
| 20-Apr-17 6:19 PM View: | Roberts Richard John Director | Invivo Therapeutics Holding... (NVIV) | 13-Apr-17 | Option Exercise | 30,984 | $0.29 | $8,997.75 | 17% 185.9K to 216.89K | |
| 17-Feb-17 3:11 PM View: | Roberts Richard John Director | Invivo Therapeutics Holding... (NVIV) | 16-Feb-17 | Option Exercise | 58,403 | $0.29 | $16,960.20 | 46% 127.5K to 185.9K | |
| 23-Aug-16 4:28 PM View: | Roberts Richard John Director | Invivo Therapeutics Holding... (NVIV) | 19-Aug-16 | Option Exercise | 70,000 | $0.29 | $20,328.00 | 122% 57.5K to 127.5K | |
| 08-Mar-16 5:36 PM View: | Roberts Richard John Director | Invivo Therapeutics Holding... (NVIV) | 10-Feb-16 | Option Exercise | 35,000 | $0.29 | $10,164.00 | 117% 30.0K to 65.0K | |
| 22-Jan-16 7:36 PM View: | Perrin Mark D CHIEF EXECUTIVE OFFICER Director | Invivo Therapeutics Holding... (NVIV) | 31-Dec-15 | Grant | 1,053 | $6.12 | $6,444.36 | 2% 57.14K to 58.2K | |
| 22-Jan-16 7:35 PM View: | McAllister Steven F Chief Financial Officer | Invivo Therapeutics Holding... (NVIV) | 31-Dec-15 | Grant | 232 | $6.12 | $1,419.84 | 1% 18.93K to 19.16K | |
| 22-Jan-16 7:34 PM View: | Lorianne Masuoka K. Chief Medical Officer | Invivo Therapeutics Holding... (NVIV) | 31-Dec-15 | Grant | 265 | $6.12 | $1,621.80 | 100% 0 to 0.27K | |
| 22-Jan-16 7:35 PM View: | Joseph Tamara L SVP, General Counsel | Invivo Therapeutics Holding... (NVIV) | 31-Dec-15 | Grant | 1,599 | $6.12 | $9,785.88 | 10% 15.43K to 17.03K | |
| 22-Jan-16 7:34 PM View: | Ulich Thomas R Chief Scientific Officer | Invivo Therapeutics Holding... (NVIV) | 31-Dec-15 | Grant | 265 | $6.12 | $1,621.80 | 1% 21.43K to 21.69K | |
| 08-Mar-16 5:36 PM View: | Roberts Richard John Director | Invivo Therapeutics Holding... (NVIV) | 29-Dec-15 | Option Exercise | 20,000 | $0.29 | $5,808.00 | 200% 10.0K to 30.0K | |
| 14-Aug-15 4:29 PM View: | Merrifield C Ann Director | Invivo Therapeutics Holding... (NVIV) | 12-Aug-15 | Purchase | 2,000 | $12.36 | $24,718.00 | 100% 0 to 2.0K | |
| 11-Dec-14 4:17 PM View: | Joseph Tamara L SVP, General Counsel | Invivo Therapeutics Holding... (NVIV) | 10-Dec-14 | Grant | 15,428 | -- | -- | 100% 0 to 15.43K | |
| 11-Dec-14 4:18 PM View: | Ulich Thomas R Chief Scientific Officer | Invivo Therapeutics Holding... (NVIV) | 10-Dec-14 | Grant | 21,428 | -- | -- | 100% 0 to 21.43K | |
| 11-Dec-14 4:17 PM View: | Perrin Mark D CHIEF EXECUTIVE OFFICER Director | Invivo Therapeutics Holding... (NVIV) | 10-Dec-14 | Grant | 57,142 | -- | -- | 100% 0 to 57.14K | |
| 11-Dec-14 4:17 PM View: | McAllister Steven F Chief Financial Officer | Invivo Therapeutics Holding... (NVIV) | 10-Dec-14 | Grant | 18,928 | -- | -- | 100% 0 to 18.93K | |
| 12-Aug-14 5:25 PM View: | Roberts Richard John Director | Invivo Therapeutics Holding... (NVIV) | 08-Aug-14 | Option Exercise | 10,000 | $0.07 | $726.00 | 100% 0 to 10.0K | |
| 09-May-14 5:41 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 09-May-14 | Sale | 12,500 | $1.20 | $15,000.00 | (< 1%) 9.08M to 9.07M | |
| 09-May-14 5:41 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 08-May-14 | Sale | 12,500 | $1.19 | $14,875.00 | (< 1%) 9.09M to 9.08M | |
| 09-May-14 5:41 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 07-May-14 | Sale | 25,000 | $1.20 | $30,000.00 | (< 1%) 9.12M to 9.09M | |
| 06-May-14 10:53 AM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 05-May-14 | Sale | 21,200 | $1.79 | $37,948.00 | (< 1%) 9.13M to 9.11M | |
| 06-May-14 10:53 AM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 02-May-14 | Sale | 3,800 | $2.05 | $7,790.00 | (< 1%) 9.12M to 9.12M | |
| 06-May-14 10:53 AM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 01-May-14 | Sale | 12,500 | $1.95 | $24,375.00 | (< 1%) 9.14M to 9.13M | |
| 01-May-14 1:27 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 30-Apr-14 | Sale | 12,500 | $1.89 | $23,625.00 | (< 1%) 9.16M to 9.14M | |
| 01-May-14 1:27 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 29-Apr-14 | Sale | 12,500 | $1.82 | $22,750.00 | (< 1%) 9.17M to 9.16M | |
| 01-May-14 1:27 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 28-Apr-14 | Sale | 12,500 | $1.76 | $22,000.00 | (< 1%) 9.18M to 9.17M | |
| 25-Apr-14 6:55 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 25-Apr-14 | Sale | 12,500 | $1.51 | $18,875.00 | (< 1%) 9.19M to 9.18M | |
| 25-Apr-14 6:55 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 24-Apr-14 | Sale | 12,500 | $1.51 | $18,875.00 | (< 1%) 9.21M to 9.19M | |
| 25-Apr-14 6:55 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 23-Apr-14 | Sale | 12,500 | $1.52 | $19,000.00 | (< 1%) 9.22M to 9.21M | |
| 25-Apr-14 6:55 PM View: | Reynolds Francis 10% Owner | Invivo Therapeutics Holding... (NVIV) | 22-Apr-14 | Sale | 12,500 | $1.52 | $19,000.00 | (< 1%) 9.23M to 9.22M |
